Tania Papkovskaia

Dr Tania Papkovskaia is a Senior Associate at Fountain Healthcare Partners. Tania qualified with a BSc in Biochemistry from University College Dublin in 2009 and earned a PhD in Clinical Neuroscience from University College London, sponsored by Eisai Limited in collaboration with the Welcome Trust Consortium and the Institute of Neurology. Her research was focused on Leucine Rich Repeat Kinase 2 in Parkinson’s Disease. In addition, she conducted postdoctoral research at the department of Oncology, University of Cambridge, investigating the role of cyclin depended kinase inhibitors in neuroblastoma.

In 2014, Tania joined the Healthcare team at the Gerson Lehrman Group, providing diligence support to global healthcare investors, coordinating business development efforts and product campaigns across pharmaceutical, biotechnology and medical device segments. In 2017, she took over the European Healthcare team, a $4.5 million division, with responsibility spanning revenue, commercial strategy, operational performance, training and development.